Index of medicine substances

Valaciclovir  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors (J05AB11)

Valdecoxib  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Coxibs (M01AH03)

Valerian  •  Nervous system | Hypnotics and sedatives | Hypnotics and sedatives in combination, excl. barbiturates (N05CXN3)

Valerian + lemon balm + mint  •  Nervous system | Hypnotics and sedatives | Hypnotics and sedatives in combination, excl. barbiturates (N05CXN3)

Valganciclovir  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors (J05AB14)

Valproic acid + salts  •  Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives (N03AG01)

Valsartan  •  Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain (C09CA03)

Valsartan + amlodipine  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers (C09DB01)

Valsartan + hydrochlorothiazide  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics (C09DA03)

Valsartan + indapamide  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics (C09DA03)

Vamorolone  •  Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids (H02AB18)

Vancomycin  •  Antiinfectives for systemic use | Other antibacterials | Glycopeptide antibacterials (J01XA01)

Vandetanib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX04)

Vardenafil  •  Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs used in erectile dysfunction (G04BE09)

Varenicline  •  Nervous system | Drugs used in addictive disorders | Drugs used in nicotine dependence (N07BA03)

Varicella-zoster vaccine (recombinant, adjuvanted)  •  Antiinfectives for systemic use | Viral vaccines | Varicella zoster vaccines (J07BK03)

Vasopressin  •  Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Vasopressin and analogues (H01BA01)

Vasopressin (argipressin)  •  Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Vasopressin and analogues (H01BA01)

Vecuronium  •  Musculo-skeletal system | Muscle relaxants | Muscle relaxants, peripherally acting agents | Other quaternary ammonium compounds (M03AC03)

Vedolizumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Monoclonal antibodies (L04AG05)

Velaglucerase alfa  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB10)

Velmanase alfa  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB15)

Vemurafenib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | B-raf serine-threonine kinase (BRAF) inhibitors (L01EC01)

Venetoclax  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents (L01XX52)

Venlafaxine  •  Nervous system | Antidepressants | Other antidepressants (N06AX16)

Verapamil  •  Cardiovascular system | Selective calcium channel blockers with direct cardiac effects | Phenylalkylamine derivatives (C08DA01)

Verapamil + trandolapril  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers (C09BB10)

Vernakalant  •  Cardiovascular system | Antiarrhythmics, class I and III | Other antiarrhythmics, class I and III (C01BG11)

Verteporfin  •  Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents (S01LA01)

Vestronidase alfa  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB18)